> Details

Gonzalez-Gil, Alida; Gomez-Ruiz, Álvaro Jesús; Gonzalez-Pérez, Carmen; Gil-Gomez, Elena; Olivares-Ripoll, Vicente; Martinez, Jerónimo; Barceló, Francisco; Cascales-Campos, Pedro Antonio

Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition
  • Contributor: Gonzalez-Gil, Alida; Gomez-Ruiz, Álvaro Jesús; Gonzalez-Pérez, Carmen; Gil-Gomez, Elena; Olivares-Ripoll, Vicente; Martinez, Jerónimo; Barceló, Francisco; Cascales-Campos, Pedro Antonio
  • Published: Springer Science and Business Media LLC, 2024
  • Published in: Annals of Surgical Oncology, 31 (2024) 10, Seite 7157-7164
  • Language: English
  • DOI: 10.1245/s10434-024-15863-z
  • ISSN: 1068-9265; 1534-4681
  • Origination:
  • Footnote:
  • Description: Abstract Background Some procedures performed during cytoreductive surgery (CRS) and hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) are based on empirical data. One of these procedures is systematic cholecystectomy. This study aimed to perform a critical analysis of the need for systematic cholecystectomy during CRS+HIPEC of patients with peritoneal carcinomatosis using long-term follow-up data. Methods Patients with peritoneal surface malignancies who were candidates for CRS+HIPEC and underwent surgery between January 2008 and December 2022 were analyzed. For patients with gallbladder involvement due to the disease or for patients whose preoperative study showed the presence of cholelithiasis, cholecystectomy was performed as part of the surgery, which was avoided for the remaining patients. All postoperative adverse events that occurred in the first 90 days were recorded, and clinical records focused on the development of biliary pathology during the follow-up period were studied. Results The results from a consecutive series of 443 patients with peritoneal surface malignancies who underwent surgery between January 2008 and December 2022 were analyzed. The average age of the cohort was 50 years. The median follow-up period for the cohort was 41 months (range, 12–180 months), with a disease-free survival of 17 months. For 373 of the patients, CRS+HIPEC was completed without an associated cholecystectomy, and in 16 of them, the appearance of cholelithiasis was detected during the follow-up period. Only two patients in the series showed complications derived from gallstones and required a delayed cholecystectomy. Conclusions Although cholecystectomy is a safe procedure in the context of CRS+HIPEC, it is not risk free, and its routine performance may be unnecessary.